2024
Auditory complications among childhood cancer survivors and health-related quality of life: a PanCareLIFE study
STREBEL, Sven, Katja BAUST, Desiree GRABOW, Julianne BYRNE, Thorsten LANGER et. al.Základní údaje
Originální název
Auditory complications among childhood cancer survivors and health-related quality of life: a PanCareLIFE study
Autoři
STREBEL, Sven, Katja BAUST, Desiree GRABOW, Julianne BYRNE, Thorsten LANGER, Antoinette Am ZEHNHOFF-DINNESEN, Rahel KUONEN, Annette WEISS, Tomáš KEPÁK, Jarmila KRUSEOVA, Claire BERGER, Gabriele CALAMINUS, Grit SOMMER a Claudia E KUEHNI
Vydání
JOURNAL OF CANCER SURVIVORSHIP, New York, SPRINGER, 2024, 1932-2259
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 3.700 v roce 2022
Organizační jednotka
Lékařská fakulta
UT WoS
001069959900001
Klíčová slova anglicky
Childhood cancer; Survivorship; Quality of life; Hearing loss; Tinnitus
Změněno: 6. 3. 2024 09:21, Mgr. Tereza Miškechová
Anotace
V originále
PurposeAuditory complications are potential side effects from childhood cancer treatment. Yet, limited evidence exists about the impact of auditory complications-particularly tinnitus-on health-related quality of life (HRQoL) among childhood cancer survivors (CCS). We determined the prevalence of hearing loss and tinnitus in the European PanCareLIFE cohort of CCS and examined its effect on HRQoL.MethodsWe included CCS from four European countries who were diagnosed at age & LE; 18 years; survived & GE; 5 years; and aged 25-44 years at study. We assessed HRQoL (Short Form 36), hearing loss, and tinnitus using questionnaires. We used multivariable linear regression to examine associations between these two auditory complications and HRQoL adjusting for socio-demographic and clinical factors.ResultsOur study population consisted of 6,318 CCS (53% female; median age at cancer diagnosis 9 years interquartile range [IQR] 5-13 years) with median age at survey of 31 years (IQR 28-35 years). Prevalence was 7.5% (476/6,318; confidence interval [CI]: 6.9-8.2) for hearing loss and 7.6% (127/1,668; CI: 6.4-9.0) for tinnitus. CCS with hearing loss had impaired physical (coefficient [coef.] -4.3, CI: -7.0 to -1.6) and mental (coef. -3.2, CI: -5.5 to -0.8) HRQoL when compared with CCS with normal hearing. Tinnitus was associated with impaired physical (coef. -8.2, CI: -11.8 to -4.7) and mental (coef. -5.9, CI: -8.8 to -3.1) HRQoL.ConclusionWe observed reduced HRQoL among CCS with hearing loss and tinnitus. Our findings indicate timely treatment of hearing loss and tinnitus may contribute to quality of life of survivors.Implications for cancer survivorsCCS who experience auditory complications should be counseled about possible therapeutic and supportive measures during follow-up care.